Lataa...
Extracellular Vesicles in Prostate Cancer: New Future Clinical Strategies?
Prostate cancer (PCa) is the most common cancer—excluding skin tumors—in men older than 50 years of age. Over time, the ability to diagnose PCa has improved considerably, mainly due to the introduction of prostate-specific antigen (PSA) in the clinical routine. However, it is important to take into...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Hindawi Publishing Corporation
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3950949/ https://ncbi.nlm.nih.gov/pubmed/24707491 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/561571 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|